Carsten Schou

Director/Board Member at

Minervax ApS

Health Technology

Finance

Consumer Services

Profile

Carsten Schou currently works at Minervax ApS, as Director.
Dr. Schou also formerly worked at ALK-Abello A, as Research Director, the University of Copenhagen, as Director-Biotechnology Research & Innovation, Celltrix AB, as Director, Valderm ApS, as Director, Neurokey A, as Director, Bok Holding A, as Director, OncoTac Pharmaceuticals ApS, as Director, EpiTherapeutics ApS, as Director, CanImGuide Therapeutics AB, as Non-Executive Director, Reapplix A, as Director, Acarix AB, as Director, Contera Pharma ApS, as Director, MedicoSelskabet September 2014 ApS, as Director, Acesion Pharma ApS, as Director, Galecto Biotech ApS, as Director, Evolva A, as Director, and Danske Private Equity A, as Principal.
Dr. Schou received his graduate degree from the University of Copenhagen and doctorate degree from Statens Serum Institute.

Carsten Schou active positions

Companies	Position	Start
Minervax ApS Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults	Director/Board Member	-

All active positions of Carsten Schou

Former positions of Carsten Schou

Companies	Position	End
SEED Capital Management I/S SEED Capital Management I/S Investment ManagersFinance SEED Capital invests in companies located in Denmark. The firm focuses on consumer, deep tech, fintech and SaaS sectors. It provides financing for seed and early stage capital requirements with an investment size of EUR 2 - 4 million. It also makes follow-on investments.	Private Equity Investor	31/03/2021
Valderm ApS Valderm ApS Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Director/Board Member	21/05/2014
OncoTac Pharmaceuticals ApS OncoTac Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of cancer diseases	Director/Board Member	02/04/2012
Neurokey A/S Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field	Director/Board Member	30/07/2010
Acesion Pharma ApS Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation	Director/Board Member	-

See the detail of Carsten Schou's experience

Training of Carsten Schou

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carsten Schou's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
ALK-Abello A/S ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions	Health Technology
Danske Private Equity A/S Danske Private Equity A/S Investment ManagersFinance DPE is an active fund of funds manager which provides funding for private equity buyout funds, and makes co-investments along its portfolio funds. The firm targets funds investing in small and mid-sized companies operating in a broad range of sectors and industries located in Europe and North America.	Finance
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SEED Capital Management I/S SEED Capital Management I/S Investment ManagersFinance SEED Capital invests in companies located in Denmark. The firm focuses on consumer, deep tech, fintech and SaaS sectors. It provides financing for seed and early stage capital requirements with an investment size of EUR 2 - 4 million. It also makes follow-on investments.	Finance
Celltrix AB Celltrix AB Miscellaneous Commercial ServicesCommercial Services Develops technologies for detecting antibiotic residues in food, diagnosing animal diseases and testing water quality	Commercial Services
Valderm ApS Valderm ApS Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Neurokey A/S Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field	Health Technology
Bok Holding A/S Bok Holding A/S BiotechnologyHealth Technology Researches and develops products based on activator systems for cancer diseases	Health Technology
OncoTac Pharmaceuticals ApS OncoTac Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of cancer diseases	Health Technology
EpiTherapeutics ApS EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics	Health Technology
Statens Serum Institute Statens Serum Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CanImGuide Therapeutics AB CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies	Health Technology
Reapplix A/S Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers	Health Technology
Acarix AB Acarix AB Medical SpecialtiesHealth Technology Provides medical device for monitoring Coronary Artery Disease	Health Technology
Contera Pharma ApS Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of patients	Health Technology
Minervax ApS Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults	Health Technology
MedicoSelskabet September 2014 ApS MedicoSelskabet September 2014 ApS Medical SpecialtiesHealth Technology Develops medical devices for cardiovascular sensing	Health Technology
Acesion Pharma ApS Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation	Commercial Services
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer	Health Technology
Evolva A/S